vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and Kennedy-Wilson Holdings, Inc. (KW). Click either name above to swap in a different company.
Kennedy-Wilson Holdings, Inc. is the larger business by last-quarter revenue ($120.6M vs $62.1M, roughly 1.9× Cytek Biosciences, Inc.). Kennedy-Wilson Holdings, Inc. runs the higher net margin — 48.1% vs -70.9%, a 119.0% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs -11.0%). Cytek Biosciences, Inc. produced more free cash flow last quarter ($-1.8M vs $-55.2M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs -6.0%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Kennedy Wilson is a real estate investment company headquartered in Beverly Hills, California, United States.
CTKB vs KW — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $120.6M |
| Net Profit | $-44.1M | $58.0M |
| Gross Margin | 52.9% | — |
| Operating Margin | -9.0% | 57.3% |
| Net Margin | -70.9% | 48.1% |
| Revenue YoY | 8.1% | -11.0% |
| Net Profit YoY | -557.1% | 32.7% |
| EPS (diluted) | — | $0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $120.6M | ||
| Q3 25 | $52.3M | $116.4M | ||
| Q2 25 | $45.6M | $135.7M | ||
| Q1 25 | $41.5M | $128.3M | ||
| Q4 24 | $57.5M | $135.5M | ||
| Q3 24 | $51.5M | $127.5M | ||
| Q2 24 | $46.6M | $132.0M | ||
| Q1 24 | $44.9M | $136.4M |
| Q4 25 | $-44.1M | $58.0M | ||
| Q3 25 | $-5.5M | $-10.2M | ||
| Q2 25 | $-5.6M | $5.6M | ||
| Q1 25 | $-11.4M | $-29.6M | ||
| Q4 24 | $9.6M | $43.7M | ||
| Q3 24 | $941.0K | $-66.8M | ||
| Q2 24 | $-10.4M | $-48.3M | ||
| Q1 24 | $-6.2M | $37.7M |
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
| Q4 25 | -9.0% | 57.3% | ||
| Q3 25 | -17.6% | -6.2% | ||
| Q2 25 | -23.3% | 7.4% | ||
| Q1 25 | -36.1% | -26.9% | ||
| Q4 24 | 5.2% | 36.7% | ||
| Q3 24 | -8.2% | -60.8% | ||
| Q2 24 | -18.3% | -45.5% | ||
| Q1 24 | -23.9% | 47.2% |
| Q4 25 | -70.9% | 48.1% | ||
| Q3 25 | -10.5% | -8.8% | ||
| Q2 25 | -12.2% | 4.1% | ||
| Q1 25 | -27.5% | -23.1% | ||
| Q4 24 | 16.8% | 32.3% | ||
| Q3 24 | 1.8% | -52.4% | ||
| Q2 24 | -22.4% | -36.6% | ||
| Q1 24 | -13.8% | 27.6% |
| Q4 25 | — | $0.22 | ||
| Q3 25 | — | $-0.15 | ||
| Q2 25 | — | $-0.05 | ||
| Q1 25 | — | $-0.30 | ||
| Q4 24 | — | $0.24 | ||
| Q3 24 | — | $-0.56 | ||
| Q2 24 | — | $-0.43 | ||
| Q1 24 | — | $0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $184.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $341.7M | $1.5B |
| Total Assets | $461.5M | $6.6B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $184.5M | ||
| Q3 25 | $93.3M | $382.6M | ||
| Q2 25 | $75.5M | $309.1M | ||
| Q1 25 | $95.3M | $356.6M | ||
| Q4 24 | $98.7M | $217.5M | ||
| Q3 24 | $162.3M | $367.1M | ||
| Q2 24 | $177.9M | $366.5M | ||
| Q1 24 | $168.8M | $541.9M |
| Q4 25 | $341.7M | $1.5B | ||
| Q3 25 | $378.6M | $1.5B | ||
| Q2 25 | $377.6M | $1.6B | ||
| Q1 25 | $379.6M | $1.6B | ||
| Q4 24 | $395.7M | $1.6B | ||
| Q3 24 | $385.5M | $1.6B | ||
| Q2 24 | $389.1M | $1.7B | ||
| Q1 24 | $392.6M | $1.7B |
| Q4 25 | $461.5M | $6.6B | ||
| Q3 25 | $494.9M | $6.7B | ||
| Q2 25 | $493.3M | $6.8B | ||
| Q1 25 | $482.6M | $7.2B | ||
| Q4 24 | $499.5M | $7.0B | ||
| Q3 24 | $491.2M | $7.4B | ||
| Q2 24 | $483.7M | $7.5B | ||
| Q1 24 | $492.1M | $7.7B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $11.4M |
| Free Cash FlowOCF − Capex | $-1.8M | $-55.2M |
| FCF MarginFCF / Revenue | -2.9% | -45.8% |
| Capex IntensityCapex / Revenue | 1.6% | 55.2% |
| Cash ConversionOCF / Net Profit | — | 0.20× |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $-103.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $11.4M | ||
| Q3 25 | $-3.9M | $-7.6M | ||
| Q2 25 | $108.0K | $42.0M | ||
| Q1 25 | $-125.0K | $-51.9M | ||
| Q4 24 | $2.0M | $55.1M | ||
| Q3 24 | $13.2M | $-5.6M | ||
| Q2 24 | $6.2M | $36.7M | ||
| Q1 24 | $4.0M | $-5.6M |
| Q4 25 | $-1.8M | $-55.2M | ||
| Q3 25 | $-4.6M | $-18.0M | ||
| Q2 25 | $-1.5M | $29.4M | ||
| Q1 25 | $-974.0K | $-59.7M | ||
| Q4 24 | $1.1M | $-76.5M | ||
| Q3 24 | $12.2M | $-27.7M | ||
| Q2 24 | $5.2M | $-500.0K | ||
| Q1 24 | $3.4M | $-57.1M |
| Q4 25 | -2.9% | -45.8% | ||
| Q3 25 | -8.7% | -15.5% | ||
| Q2 25 | -3.2% | 21.7% | ||
| Q1 25 | -2.3% | -46.5% | ||
| Q4 24 | 1.9% | -56.5% | ||
| Q3 24 | 23.7% | -21.7% | ||
| Q2 24 | 11.0% | -0.4% | ||
| Q1 24 | 7.6% | -41.9% |
| Q4 25 | 1.6% | 55.2% | ||
| Q3 25 | 1.3% | 8.9% | ||
| Q2 25 | 3.5% | 9.3% | ||
| Q1 25 | 2.0% | 6.1% | ||
| Q4 24 | 1.6% | 97.1% | ||
| Q3 24 | 2.0% | 17.3% | ||
| Q2 24 | 2.3% | 28.2% | ||
| Q1 24 | 1.3% | 37.8% |
| Q4 25 | — | 0.20× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 7.50× | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | 1.26× | ||
| Q3 24 | 14.05× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -0.15× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
KW
| Consolidated Portfolio Segment | $84.9M | 70% |
| Investment Management Fees | $30.4M | 25% |
| Real Estate | $5.1M | 4% |
